Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Clinical Reviews in Allergy & Immunology
|
July 19, 2020
Machine Learning in Rheumatic Diseases
Mengdi Jiang, Yueting Li, Chendan Jiang, et al.
Clinical Nuclear Medicine
|
November 19, 2020
Quantitative Features From CHO PET Distinguish the WHO Grades of Primary Diffuse Glioma
Ziren Kong, Chendan Jiang, Delin Liu, et al.
Bioengineering (Basel, Switzerland)
|
November 25, 2023
Machine Learning Approaches to Differentiate Sellar-Suprasellar Cystic Lesions on Magnetic Resonance Imaging
Chendan Jiang, Wentai Zhang, He Wang, et al.
BMC Neuroscience
|
December 5, 2022
Feasibility of evaluating the histologic and genetic subtypes of WHO grade II-IV gliomas by diffusion-weighted imaging
Sirui Liu, Yiwei Zhang, Ziren Kong, et al.
Angiogenesis
|
December 5, 2024
Inhibition of Angiopoietin-2 rescues sporadic brain arteriovenous malformations by reducing pericyte loss
Tianqi Tu, Shikun Zhang, Jingwei Li, et al.
Neuroimage. Clinical
|
September 8, 2019
<sup>18</sup>F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma
Ziren Kong, Chendan Jiang, Ruizhe Zhu, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
August 21, 2019
<sup>18</sup>F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma
Ziren Kong, Yusong Lin, Chendan Jiang, et al.
Neuroendocrinology
|
July 19, 2019
Deep-Learning Approach to Automatic Identification of Facial Anomalies in Endocrine Disorders
Ren Wei, Chendan Jiang, Jun Gao, et al.
Neuroradiology
|
April 3, 2020
Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas
Chendan Jiang, Ziren Kong, Yiwei Zhang, et al.
European Journal of Radiology
|
November 10, 2019
Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas
Chendan Jiang, Ziren Kong, Sirui Liu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Clinical Reviews in Allergy & Immunology
|
July 19, 2020
Machine Learning in Rheumatic Diseases
Mengdi Jiang, Yueting Li, Chendan Jiang, et al.
Clinical Nuclear Medicine
|
November 19, 2020
Quantitative Features From CHO PET Distinguish the WHO Grades of Primary Diffuse Glioma
Ziren Kong, Chendan Jiang, Delin Liu, et al.
Bioengineering (Basel, Switzerland)
|
November 25, 2023
Machine Learning Approaches to Differentiate Sellar-Suprasellar Cystic Lesions on Magnetic Resonance Imaging
Chendan Jiang, Wentai Zhang, He Wang, et al.
BMC Neuroscience
|
December 5, 2022
Feasibility of evaluating the histologic and genetic subtypes of WHO grade II-IV gliomas by diffusion-weighted imaging
Sirui Liu, Yiwei Zhang, Ziren Kong, et al.
Angiogenesis
|
December 5, 2024
Inhibition of Angiopoietin-2 rescues sporadic brain arteriovenous malformations by reducing pericyte loss
Tianqi Tu, Shikun Zhang, Jingwei Li, et al.
Neuroimage. Clinical
|
September 8, 2019
<sup>18</sup>F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma
Ziren Kong, Chendan Jiang, Ruizhe Zhu, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
August 21, 2019
<sup>18</sup>F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma
Ziren Kong, Yusong Lin, Chendan Jiang, et al.
Neuroendocrinology
|
July 19, 2019
Deep-Learning Approach to Automatic Identification of Facial Anomalies in Endocrine Disorders
Ren Wei, Chendan Jiang, Jun Gao, et al.
Neuroradiology
|
April 3, 2020
Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas
Chendan Jiang, Ziren Kong, Yiwei Zhang, et al.
European Journal of Radiology
|
November 10, 2019
Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas
Chendan Jiang, Ziren Kong, Sirui Liu, et al.
Page
of 2